Haematopoietic action of flt3 ligand on cord blood‐derived CD34‐positive cells expressing different levels of flt3 or c‐kit tyrosine kinase receptor: comparison with stem cell factor

We compared the effect of human flt3 ligand (FL) and stem cell factor (SCF) on cord blood (CB)‐derived CD34+ cells expressing different levels of flt3 or c‐kit tyrosine kinase (TK) receptor in clonal cell culture. The c‐kit receptor was expressed by 58.5±16.7% of CB CD34+ cells (n = 19), in which c‐kithigh, c‐kitlow and c‐kit‐ cell populations could be identified. In contrast, the flt3 receptor (FR) was weakly expressed on 58.6±8.3% (n = 9) of CB CD34+ cells. FL+erythropoietin (Epo) failed to support erythroid burst (BFU–E) formation by any subpopulation of CD34+ cells. However, SCF+Epo supported BFU–E and erythrocyte‐containing mixed (CFU–mix) colony formation from all subpopulations. Interestingly, FL markedly augmented CFU–mix colony formation supported by interleukin (IL)‐ 3+Epo when CD34+c‐kitlow or CD34+FR+ cells were used as the target. On the other hand, SCF significantly enhanced CFU‐mix colony formation supported by IL‐3+Epo when CD34+c‐kithigh or low and CD34+FR+ cells were used. The replating potential of CFU–mix supported by IL‐3 + Epo + FL was greater when CD34+c‐kitlow or CD34+FR+ cells were used. When the CD34+c‐kitlow cells were used, the number of lineages expressed in secondary cultures of CFU–mix colonies derived from primary cultures containing IL‐3 + Epo+FL or SCF was significantly larger than when the primary cultures contained IL‐3+Epo. Furthermore, the number of long‐term culture‐initiating cells found in CD34+FR+ cells was larger than that in FR‐ cells. CB‐derived CD34+c‐kitlow cells represent a less mature population than c‐kithigh cells, as reported previously. Therefore, these results indicate that both FL and SCF can act on primitive multipotential progenitors. However, it is still uncertain whether CB‐derived CD34+FR+ cells are less mature than CD34+FR‐ cells.

[1]  Y. Sonoda,et al.  Human cord blood-derived primitive progenitors are enriched in CD34+c-kit− cells: correlation between long-term culture-initiating cells and telomerase expression , 1998, Leukemia.

[2]  A. Zannettino,et al.  Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase. , 1997, Blood.

[3]  Y. Sonoda,et al.  Human FLT3 ligand acts on myeloid as well as multipotential progenitors derived from purified CD34+ blood progenitors expressing different levels of c‐kit protein , 1997, European journal of haematology.

[4]  H. Miyazaki,et al.  Thrombopoietin augments ex vivo expansion of human cord blood-derived hematopoietic progenitors in combination with stem cell factor and flt3 ligand , 1997, Leukemia.

[5]  Y. Sonoda,et al.  Action of human interleukin‐4 and stem cell factor on erythroid and mixed colony formation by peripheral blood‐derived CD34+c‐kithigh or CD34+c‐kitlow cells , 1997, British journal of haematology.

[6]  Y. Sonoda,et al.  Functional Differences between Subpopulations of Mobilized Peripheral Blood‐Derived CD34+ Cells Expressing Different Levels of HLA‐DR, CD33, CD38 and c‐kit Antigens , 1997, Stem cells.

[7]  V. Broudy,et al.  FLT3 receptor expression on the surface of normal and malignant human hematopoietic cells. , 1996, Blood.

[8]  R. Willemze,et al.  Haemopoietic growth factor tyrosine kinase receptor expression profiles in normal haemopoiesis , 1996, British journal of haematology.

[9]  I. Bernstein,et al.  Regulation of colony forming cell generation by flt‐3 ligand , 1996, British journal of haematology.

[10]  M. Ogawa,et al.  CD34+ human marrow cells that express low levels of Kit protein are enriched for long-term marrow-engrafting cells. , 1996, Blood.

[11]  S. Jacobsen,et al.  The FLT3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34+ bone marrow progenitor cells in vitro. , 1996, Blood.

[12]  L. Ashman,et al.  Characterization of c-kit expression by primitive hematopoietic progenitors in umbilical cord blood. , 1995, Experimental hematology.

[13]  David A. Williams,et al.  Effect of flt3 ligand on the ex vivo expansion of human CD34+ hematopoietic progenitor cells. , 1995, Blood.

[14]  H. Broxmeyer,et al.  Flt3 ligand stimulates/costimulates the growth of myeloid stem/progenitor cells. , 1995, Experimental hematology.

[15]  U. Testa,et al.  Multi-level effects of flt3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors. , 1995, Blood.

[16]  P. D. Vries,et al.  Expression of the flt3 receptor and its ligand on hematopoietic cells. , 1995, Leukemia.

[17]  R. Kastelein,et al.  FLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver. , 1995, Blood.

[18]  S. Nakagawa,et al.  Synergistic actions of stem cell factor and other burst-promoting activities on proliferation of CD34+ highly purified blood progenitors expressing HLA-DR or different levels of c-kit protein. , 1994, Blood.

[19]  Carroll,et al.  Cellular and molecular characterization of the role of the flk-2/flt-3 receptor tyrosine kinase in hematopoietic stem cells. , 1994, Blood.

[20]  K. Itoh,et al.  Development of a tissue culture assay system for Campylobacter jejuni cytotoxin and the influence of culture conditions on cytotoxin production. , 1994, Journal of medical microbiology.

[21]  H. Mckenna,et al.  Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells. , 1994, Blood.

[22]  T. Mcclanahan,et al.  Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs , 1994, Nature.

[23]  M. Ratajczak,et al.  STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  T. Farrah,et al.  Molecular cloning of a ligand for the flt3 flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells , 1993, Cell.

[25]  H. Nakauchi,et al.  Human primitive hematopoietic progenitor cells are more enriched in KITlow cells than in KIThigh cells. , 1993, Blood.

[26]  T. Bird,et al.  Characterization of the protein encoded by the flt3 (flk2) receptor-like tyrosine kinase gene. , 1993, Oncogene.

[27]  D. Birnbaum,et al.  Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF1R family. , 1991, Oncogene.

[28]  D. Pardoll,et al.  A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations , 1991, Cell.

[29]  D. Williams,et al.  Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells. , 1991, Blood.

[30]  K. Zsebo,et al.  Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages. , 1991, Experimental hematology.

[31]  N. Copeland,et al.  Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles , 1990, Cell.

[32]  P. Lansdorp,et al.  Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. , 1989, Blood.

[33]  V. Chapman,et al.  The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus , 1988, Nature.

[34]  Y. Sonoda,et al.  Analysis in serum-free culture of the targets of recombinant human hemopoietic growth factors: interleukin 3 and granulocyte/macrophage-colony-stimulating factor are specific for early developmental stages. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Stinski,et al.  The use of biotinylated monoclonal antibodies and streptavidin affinity chromatography to isolate herpesvirus hydrophobic proteins or glycoproteins. , 1987, Analytical biochemistry.

[36]  C. Sherr,et al.  Specific binding of the mononuclear phagocyte colony-stimulating factor CSF-1 to the product of the v-fms oncogene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[37]  E. Stanley,et al.  CSF‐1—A mononuclear phagocyte lineage‐specific hemopoietic growth factor , 1983, Journal of cellular biochemistry.